160 related articles for article (PubMed ID: 22922226)
1. Outcome of cystic fibrosis-related diabetes two years after lung transplantation.
Valour F; Brault C; Abbas-Chorfa F; Martin C; Kessler L; Kanaan R; Mosnier-Pudar H; Coltey B; Nove-Josserand R; Durupt S; Colin C; Durieu I
Respiration; 2013; 86(1):32-8. PubMed ID: 22922226
[TBL] [Abstract][Full Text] [Related]
2. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis-related diabetes before lung transplantation is associated with lower survival but does not affect long-term renal function.
Mainbourg S; Philit F; Touzet S; Nove-Josserand R; Durupt S; Sénéchal A; Occelli P; Poupon-Bourdy S; Maury JM; Tronc F; Mornex JF; Durieu I; Reynaud Q
Pediatr Pulmonol; 2019 Jul; 54(7):977-983. PubMed ID: 30854801
[TBL] [Abstract][Full Text] [Related]
4. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of glucose intolerance in cystic fibrosis.
Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
[TBL] [Abstract][Full Text] [Related]
6. Relationship between exercise capacity and glucose tolerance in cystic fibrosis.
Foster K; Huang G; Zhang N; Crisalli J; Chini B; Amin R; Elder D
Pediatr Pulmonol; 2018 Feb; 53(2):154-161. PubMed ID: 29115018
[TBL] [Abstract][Full Text] [Related]
7. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
8. Clinical importance of cystic fibrosis-related diabetes.
Brennan AL; Geddes DM; Gyi KM; Baker EH
J Cyst Fibros; 2004 Dec; 3(4):209-22. PubMed ID: 15698938
[TBL] [Abstract][Full Text] [Related]
9. Glucose intolerance in cystic fibrosis patients.
Lanng S
Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
Hameed S; Jaffé A; Verge CF
Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
[TBL] [Abstract][Full Text] [Related]
12. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
[TBL] [Abstract][Full Text] [Related]
14. Insulinogenic index and early phase insulin secretion predict increased risk of worsening glucose tolerance and of cystic fibrosis-related diabetes.
Potter KJ; Boudreau V; Bonhoure A; Tremblay F; Lavoie A; Carricart M; Senior PA; Rabasa-Lhoret R
J Cyst Fibros; 2023 Jan; 22(1):50-58. PubMed ID: 36028423
[TBL] [Abstract][Full Text] [Related]
15. Screening for cystic fibrosis-related diabetes: a systematic review.
Waugh N; Royle P; Craigie I; Ho V; Pandit L; Ewings P; Adler A; Helms P; Sheldon C
Health Technol Assess; 2012; 16(24):iii-iv, 1-179. PubMed ID: 22572153
[TBL] [Abstract][Full Text] [Related]
16. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.
Terliesner N; Vogel M; Steighardt A; Gausche R; Henn C; Hentschel J; Kapellen T; Klamt S; Gebhardt J; Kiess W; Prenzel F
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):815-821. PubMed ID: 28245190
[TBL] [Abstract][Full Text] [Related]
17. Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis.
Darukhanavala A; Van Dessel F; Ho J; Hansen M; Kremer T; Alfego D
PLoS One; 2021; 16(4):e0250036. PubMed ID: 33882078
[TBL] [Abstract][Full Text] [Related]
18. Cystic Fibrosis-Related Diabetes with strict glycaemic control is not associated with frequent intravenous antibiotics use for pulmonary infections.
Belle-van Meerkerk G; de Valk HW; Stam-Slob MC; Teding van Berkhout F; Zanen P; van de Graaf EA
Diabetes Res Clin Pract; 2016 Jun; 116():230-6. PubMed ID: 27321340
[TBL] [Abstract][Full Text] [Related]
19. Effect of CFTR modulator therapy on cystic fibrosis-related diabetes.
Gaines H; Jones KR; Lim J; Medhi NF; Chen S; Scofield RH
J Diabetes Complications; 2021 Jun; 35(6):107845. PubMed ID: 33558149
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and efficacy of combined pancreatic islet-lung transplantation in cystic fibrosis-related diabetes-PIM study: A multicenter phase 1-2 trial.
Rakotoarisoa L; Wagner C; Munch M; Renaud Picard B; Grenet D; Olland A; Greget M; Enescu I; Bouilloud F; Bonnette P; Guth A; Bosco D; Mercier C; Rabilloud M; Berney T; Yves Benhamou P; Massard G; Camilo C; Colin C; Arnold C; Kessler R; Kessler L;
Am J Transplant; 2022 Jul; 22(7):1861-1872. PubMed ID: 35403818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
